The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats.

Abstract

BACKGROUND/AIMS:

Diabetic nephropathy remains a major clinical problem. The effects of prorenin might be adverse, but the literature data are controversial. We compared the renal effects of the (pro)renin receptor ((P)RR) blockade and angiotensin converting enzyme (ACE) inhibition on the progression of diabetic nephropathy in rats.

METHODS:

Diabetes (DM) was induced by ip. streptozotocin administration in adult male Sprague-Dawley rats, followed by eight weeks of treatment with the (P)RR blocker "handle region" decoy peptide (HRP, 0,1 mg/kg/day) or with the ACE inhibitor Quinapril (Q, 50 mg/kg/day) and grouped as follows: 1. Control (n=10); 2. DM (n=8); 3. DM+HRP (n=6); 4. DM+Q (n=10); 5. DM+Q+HRP (n=10). Renal functional parameters, histology and gene expressions were evaluated.

RESULTS:

HRP reduced glomerulosclerosis and podocyte desmin expression, but did not affect proteinuria and tubular ERK(1/2) phosphorylation. Both Q and Q+HRP treatment reduced proteinuria, glomerular and tubular damage, tubular TGF-ß1 expression and ERK(1/2) phosphorylation to the same extent.

CONCLUSION:

The effects of HRP were partially beneficial on diabetic kidney lesions as HRP reduced damage but did not improve tubular damage and failed to reduce ERK(1/2) phosphorylation in rats. The combination of HRP with Quinapril had no additive effects over Quinapril monotherapy on the progression of diabetic nephropathy.

• Authors: Gábor Kökény, Lilla Fang, Csaba Révész, Miklós M Mózes, Péter Vörös, Gábor Szénási, László Rosivall
• Journal: Kidney & blood pressure research (Kidney Blood Press Res) Vol. 42 Issue 1 Pg. 109-122 ( 2017) ISSN: 1423-0143 [Electronic] Switzerland
• PMID: 28359068 (Publication Type: Journal Article)
• Copyright: © 2017 The Author(s)Published by S. Karger AG, Basel.

Chemical References

• Tetrahydroisoquinolines
• Renin
• Quinapril

Topics

• Animals
• Diabetes Mellitus, Experimental
• Diabetic Nephropathies (drug therapy)
• Drug Interactions
• Drug Therapy, Combination
• Kidney (drug effects, pathology)
• MAP Kinase Signaling System (drug effects)
• Male
• Quinapril
• Rats
• Rats, Sprague-Dawley
• Renin (pharmacology, therapeutic use)
• Tetrahydroisoquinolines (pharmacology, therapeutic use)